Incidence of Transitional Cell Carcinoma of the Bladder and Arsenic Exposure in New Hampshire

AbstractObjective: Arsenic is a known bladder carcinogen and populations exposed to high arsenic levels in their water supply have reported elevated bladder cancer mortality and incidence rates. To examine the effects of lower levels of arsenic exposure on bladder cancer incidence, we conducted a case–control study in New Hampshire, USA where levels above 10 μ/l are commonly found in private wells. Methods: We studied 383 cases of transitional cell carcinoma of the bladder cancer, newly diagnosed between July 1, 1994 and June 30, 1998 and 641 general population controls. Individual exposure to arsenic was determined in toenail clippings using instrumental neutron activation analysis. Results: Among smokers, an elevated odds ratio (OR) for bladder cancer was observed for the uppermost category of arsenic (OR: 2.17, 95% CI: 0.92–5.11 for greater than 0.330 mcg/g compared to less than 0.06 μ/g). Among never smokers, there was no association between arsenic and bladder cancer risk. Conclusions: These, and other data, suggest that ingestion of low to moderate arsenic levels may affect bladder cancer incidence, and that cigarette smoking may act as a co-carcinogen.

[1]  T. Tosteson,et al.  Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. , 1998, Environmental health perspectives.

[2]  Liang Jh,et al.  Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. , 1989 .

[3]  B. Chiswell,et al.  Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene. , 2002, Toxicology letters.

[4]  C. Chen,et al.  Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. , 1989, American journal of epidemiology.

[5]  R. Hoover,et al.  High bladder cancer mortality in rural New England (United States): An etiologic study , 1995, Cancer Causes & Control.

[6]  How-Ran Guo,et al.  The incidence of bladder cancer in the black foot disease endemic area in Taiwan. , 1993, British journal of urology.

[7]  M. Karagas,et al.  The study of human nails as an intake monitor for arsenic using neutron activation analysis , 1998 .

[8]  M. Maloney.  Ingested arsenic and internal cancer: a historical cohort study followed for 33 years , 1996 .

[9]  C. J. Chen,et al.  Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. , 1990, Cancer research.

[10]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[11]  Thomas J. Smith,et al.  Arsenic methylation and bladder cancer risk in Taiwan , 2003, Cancer Causes & Control.

[12]  J. Wiencke,et al.  Inhibition of poly(ADP-ribose) polymerase by arsenite. , 1997, Mutation research.

[13]  A H Smith,et al.  Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. , 1998, American journal of epidemiology.

[14]  N. Breslow,et al.  The analysis of case-control studies , 1980 .

[15]  T. Tosteson,et al.  Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. , 2000, American journal of epidemiology.

[16]  J. Wiencke,et al.  Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. , 1997, Mutation research.

[17]  W. Willett,et al.  Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. , 1995, American journal of epidemiology.

[18]  J. Cuzick,et al.  Ingested arsenic, keratoses, and bladder cancer. , 1992, American journal of epidemiology.

[19]  S. Lipsitz,et al.  Arsenic in Drinking Water and Incidence of Urinary Cancers , 1997, Epidemiology.

[20]  S. You,et al.  A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. , 1986, British Journal of Cancer.

[21]  A H Smith,et al.  Case-control study of bladder cancer and arsenic in drinking water. , 1995, American journal of epidemiology.

[22]  C. Hopenhayn-Rich,et al.  Bladder Cancer Mortality Associated with Arsenic in Drinking Water in Argentina , 1996, Epidemiology.

[23]  D. Liebler,et al.  Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. , 2001, Chemical research in toxicology.

[24]  T. Tosteson,et al.  Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. , 2001, American journal of epidemiology.

[25]  D. R. Lewis,et al.  Drinking water arsenic in Utah: A cohort mortality study. , 1999, Environmental health perspectives.

[26]  W. Willett,et al.  Toenail trace element levels as biomarkers: reproducibility over a 6-year period. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  M. Karagas,et al.  FAST TRACK DECREASED DNA REPAIR GENE EXPRESSION AMONG INDIVIDUALS EXPOSED TO ARSENIC IN UNITED STATES DRINKING WATER , 2003 .

[28]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[29]  Manuel Cebrian,et al.  Cancer Risk in an Arsenic-Contaminated Area of Chile , 1997, Toxicology and industrial health.

[30]  C. Chen,et al.  Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. , 2001, American journal of epidemiology.

[31]  Y. Hsueh,et al.  Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. , 1995, Cancer research.

[32]  E. Guallar,et al.  Use of two-segmented logistic regression to estimate change-points in epidemiologic studies. , 1998, American journal of epidemiology.

[33]  C. J. Chen,et al.  Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. , 1985, Cancer research.

[34]  Y. Ko,et al.  Mortality for certain diseases in areas with high levels of arsenic in drinking water. , 1999, Archives of environmental health.

[35]  T. Tosteson,et al.  Markers of low level arsenic exposure for evaluating human cancer risks in a US population. , 2001, International journal of occupational medicine and environmental health.

[36]  M. Vahter.  Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. , 2000, Toxicology letters.

[37]  Margaret R Karagas,et al.  Assessment of cancer risk and environmental levels of arsenic in New Hampshire. , 2002, International journal of hygiene and environmental health.

[38]  N. Altman.  An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression , 1992 .

[39]  A. Auvinen,et al.  Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. , 1999, Environmental health perspectives.